Ascentifi
Ascentifi is a venture capital firm founded in 2020 and based in Galway, Ireland. The company specializes in facilitating investments in the life sciences sector, particularly focusing on MedTech startups. Ascentifi aims to simplify the investment process, enabling investors to create customized portfolios tailored to their specific interests and goals within the MedTech industry. By concentrating on innovative life sciences ventures, Ascentifi seeks to support the development of groundbreaking technologies and solutions that can advance healthcare outcomes.
CroíValve is a developed a safe, effective, easy to use, percutaneous solution for treating all patients with severe Tricuspid Regurgitation
Vertigenius designs and deploys customized exercises using an easy-to-use clinician portal and even uses a Vertigenius head sensor to consult and manage patients with dizziness and imbalance.
X-BOLT Orthopaedics developed a novel expanding bolt device, with associated implants and instrumentation systems, for internal bone fixation in osteoporotic hip fractures. X-BOLT hip plating and nailing systems allow surgeons choice to treat all morphologies of proximal femoral fractures.
Bluedrop Medical Limited specializes in developing, manufacturing, and commercializing an Internet of Things-enabled device designed for the early detection of diabetic foot ulcers. Founded in 2014 and based in Galway, Ireland, the company offers a home-based system that conducts daily scans of patients' feet. This data is then transmitted to the cloud for analysis using advanced algorithms capable of identifying abnormalities. By detecting skin damage early, the device aims to significantly reduce the risk of amputation, which is a critical concern as up to 25% of individuals with diabetes may develop foot ulcers, often due to peripheral neuropathy. The innovative technology not only enhances patient care but also has the potential to lower healthcare costs associated with severe complications arising from untreated foot ulcers.
CroíValve is a developed a safe, effective, easy to use, percutaneous solution for treating all patients with severe Tricuspid Regurgitation
ProVerum Medical is a medtech company focused on developing innovative minimally invasive devices for the treatment of benign prostatic hyperplasia (BPH). Its technology offers a safer and more effective approach to BPH treatment, allowing patients to receive care in a doctor's office or operating room with reduced invasiveness compared to traditional methods. The device addresses the enlargement of the prostate gland, which can lead to urinary difficulties, by being placed inside the urethra to restore normal urinary function. This advancement enables healthcare providers to offer improved treatment options for patients suffering from this condition.
Tympany is a platform for performing minimally invasive ear surgeries, reducing unnecessary mastoidectomys and improving outcomes.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.